Danaher Corporation $DHR Shares Sold by Atom Investors LP

Atom Investors LP reduced its stake in shares of Danaher Corporation (NYSE:DHR) by 18.5% during the 4th quarter, Holdings Channel.com reports. The firm owned 19,861 shares of the conglomerate’s stock after selling 4,515 shares during the quarter. Atom Investors LP’s holdings in Danaher were worth $4,547,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. JPL Wealth Management LLC acquired a new stake in Danaher during the 3rd quarter worth about $25,000. Elevated Capital Advisors LLC acquired a new stake in Danaher during the 4th quarter worth about $26,000. WFA of San Diego LLC acquired a new stake in Danaher during the 2nd quarter worth about $26,000. ANTIPODES PARTNERS Ltd acquired a new stake in Danaher during the 3rd quarter worth about $27,000. Finally, Hilton Head Capital Partners LLC acquired a new stake in Danaher during the 4th quarter worth about $27,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Trading Up 0.3%

Shares of Danaher stock opened at $181.57 on Wednesday. The firm has a market capitalization of $128.51 billion, a PE ratio of 35.12, a P/E/G ratio of 2.31 and a beta of 0.81. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The firm’s 50-day moving average price is $180.54 and its 200 day moving average price is $203.94. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. During the same period last year, the company posted $1.88 EPS. Danaher’s quarterly revenue was up 3.7% compared to the same quarter last year. On average, sell-side analysts predict that Danaher Corporation will post 8.45 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is 30.95%.

Analysts Set New Price Targets

DHR has been the topic of several analyst reports. Royal Bank Of Canada initiated coverage on Danaher in a research report on Thursday, May 14th. They set an “outperform” rating and a $200.00 price target on the stock. Jefferies Financial Group reissued a “buy” rating and set a $245.00 target price on shares of Danaher in a research note on Tuesday, April 21st. Wolfe Research lowered shares of Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. JPMorgan Chase & Co. lowered their target price on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 22nd. Finally, Evercore increased their target price on shares of Danaher from $225.00 to $232.00 and gave the stock an “outperform” rating in a research note on Tuesday, April 21st. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $233.61.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.